Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7 Colorectal Neoplasms 6 Stomach Neoplasms 4 Biliary Tract Neoplasms 4 Esophageal Neoplasms 3 Neoplasms 2 Gallbladder Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer (MIBC) 1 Metastatic HER2-positive Breast Cancer 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 HER2-expressing Cancers 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced Malignancies 1

Interventions

pembrolizumab 105 Specimen Handling 55 Magnetic Resonance Spectroscopy 48 Biopsy 47 Nivolumab 40 Paclitaxel 35 Gemcitabine 30 Radiosurgery 29 Carboplatin 28 Irinotecan 22 Ipilimumab 22 Cyclophosphamide 22 Cisplatin 22 trastuzumab deruxtecan 21 Leucovorin 19 Capecitabine 19 Fluorouracil 18 Cetuximab 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 18 Pemetrexed 17 Fulvestrant 17 Drug Therapy 16 Docetaxel 16 Taxes 15 Oxaliplatin 15 olaparib 14 abemaciclib 14 Radiotherapy 14 palbociclib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × zanidatamab × 1 year × Clear all

NCT07176312 2026-02-04

ZANGEA

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Recruiting

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡